GSK: Time to rethink chronic hepatitis B: Quantitative hepatitis B surface antigen today and tomorrow (Complete Session) - EASL Congress 2024
View
Metabolism, Alcohol & Toxicity
1
GSK: Unlocking the genetic architecture of Steatotic Liver Disease. A new paradigm in patient management (Complete Session) - EASL Congress 2024
View
Metabolism, Alcohol & Toxicity
1
GSK: Meet the Experts - Genetic architecture of Steatotic Liver Disease (Complete Session) - EASL Congress 2024
View
Viral Hepatitis
1
GSK: Time to rethink chronic hepatitis B: A roadmap to functional cure (Complete Session) - EASL Congress 2024
View
Metabolism, Alcohol & Toxicity
6
AKH: Entering a New Era in Metabolic Dysfunction-Associated Steatohepatitis: Examining the Clinical Implications of Emerging Disease-Specific Therapies - EASL Congress 2024
View
Metabolism, Alcohol & Toxicity
6
AKH: Entering a New Era in Metabolic Dysfunction-Associated Steatohepatitis: Examining the Clinical Implications of Emerging Disease-Specific Therapies - EASL Congress 2024
View
Metabolism, Alcohol & Toxicity
6
AKH: Entering a New Era in Metabolic Dysfunction-Associated Steatohepatitis: Examining the Clinical Implications of Emerging Disease-Specific Therapies - EASL Congress 2024
View
Metabolism, Alcohol & Toxicity
6
AKH: Entering a New Era in Metabolic Dysfunction-Associated Steatohepatitis: Examining the Clinical Implications of Emerging Disease-Specific Therapies - EASL Congress 2024
View
Metabolism, Alcohol & Toxicity
6
AKH: Entering a New Era in Metabolic Dysfunction-Associated Steatohepatitis: Examining the Clinical Implications of Emerging Disease-Specific Therapies - EASL Congress 2024
View
Metabolism, Alcohol & Toxicity
6
AKH: Entering a New Era in Metabolic Dysfunction-Associated Steatohepatitis: Examining the Clinical Implications of Emerging Disease-Specific Therapies - EASL Congress 2024
